While cancer survival rates have significantly improved over the past 50 years, with half of patients now surviving, experts are concerned about the lack of progress in treating certain deadly cancers. These include pancreatic, lung, and brain cancers, where survival rates remain stubbornly low. Researchers are calling for increased funding and focused research efforts to address these challenging diseases and improve outcomes for all cancer patients. The report highlights the urgent need for innovation and targeted therapies to tackle the cancers that continue to claim too many lives.